GenKyoTex S.A. buy melinda
Start price
30.01.18
/
50%
€17.98
Target price
31.07.18
€19.00
Performance (%)
-6.45%
End price
31.07.18
€16.82
Summary
This prediction ended on 31.07.18 with a price of €16.82. With a performance of -6.45%, the BUY prediction by melinda finished with a loss. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
GenKyoTex S.A. | - | - | - | - |
iShares Core DAX® | 1.776% | 3.175% | 14.882% | 17.660% |
iShares Nasdaq 100 | -1.037% | 1.869% | 35.463% | 52.324% |
iShares Nikkei 225® | -0.335% | 3.857% | 14.485% | 11.459% |
iShares S&P 500 | 0.854% | 2.567% | 31.105% | 47.441% |
According to melinda what are the pros and cons of GenKyoTex S.A. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread GenKyoTex S.A. diskutieren
Biotechnologie und Medizintechnik SecteurRecherche Agenda 31/01 Publishing Business-Trends
![logo GenKyoTex Logo Genkyotex](http://logos.cofisem.fr/FR0011790542.jpg)
Am Ende 2016 hat die Gruppe einen Portfolio von 2 Produkten: GKT831 (Behandlung von primär biliäre Cholangitis) und GKT771 (Behandlung von Schmerzen und Entzündungen).
Anzahl der Angestellten: 7 Personen.
(Laufzeit überschritten)
Stopped prediction by melinda for GenKyoTex S.A.
GenKyoTex S.A.
Start price
Target price
Perf. (%)
€3.18
28.09.21
28.09.21
€3.60
-
24.10.21
24.10.21
Could be worthwhile Investment >10% per year
GenKyoTex S.A.
Start price
Target price
Perf. (%)
€44.70
15.06.16
15.06.16
€50.00
16.12.16
16.12.16
-40.72%
16.12.16
16.12.16
Could be worthwhile Investment >10% per year
GenKyoTex S.A.
Start price
Target price
Perf. (%)
€41.80
07.04.16
07.04.16
€50.00
21.04.16
21.04.16
26.08%
21.04.16
21.04.16
Could be worthwhile Investment >10% per year